Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.
暂无分享,去创建一个
P. Borst | H. Spits | O. van Tellingen | W. Fibbe | A. Schinkel | M. A. van der Valk | E. Wagenaar | O. Tellingen | C. Mol | A H Schinkel | P Borst | H Spits | W E Fibbe | E Wagenaar | L van Deemter | C A Mol | L. van Deemter | J J Smit | O van Tellingen | U Mayer | M A van der Valk | A C Voordouw | J M Zijlmans | J. Smit | J. Zijlmans | U. Mayer | W. Fibbe | A. Voordouw | L. Deemter | P. Borst | M. V. D. Valk | L. V. Deemter
[1] I. Roninson. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo. , 1992, Biochemical pharmacology.
[2] D. Housman,et al. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues , 1989, Molecular and cellular biology.
[3] P. Gros,et al. A mechanism for P-glycoprotein action in multidrug resistance: are we there yet? , 1994, Trends in pharmacological sciences.
[4] P. Borst,et al. What have we learnt thus far from mice with disrupted P-glycoprotein genes? , 1996, European journal of cancer.
[5] H. Koepsell,et al. Drug excretion mediated by a new prototype of polyspecific transporter , 1994, Nature.
[6] P. Borst,et al. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. , 1995, The Journal of clinical investigation.
[7] A. Schinkel,et al. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. , 1996, The Journal of clinical investigation.
[8] R Hori,et al. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. , 1992, The Journal of biological chemistry.
[9] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[10] S. Horwitz,et al. Differential overexpression of three mdr gene family members in multidrug-resistant J774.2 mouse cells. Evidence that distinct P-glycoprotein precursors are encoded by unique mdr genes. , 1989, The Journal of biological chemistry.
[11] J. Endicott,et al. The biochemistry of P-glycoprotein-mediated multidrug resistance. , 1989, Annual review of biochemistry.
[12] A. S. Conner,et al. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.
[13] O. Stutman,et al. The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3 , 1983, The Journal of experimental medicine.
[14] R. Miller,et al. Extrusion of the P glycoprotein substrate rhodamine-123 distinguishes CD4 memory T cell subsets that differ in IL-2-driven IL-4 production. , 1994, Journal of immunology.
[15] S. Zhao,et al. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. , 1992, Blood.
[16] P. Borst,et al. Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease , 1993, Cell.
[17] G. Johnson,et al. Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells , 1992, The Journal of experimental medicine.
[18] P. Meltzer,et al. Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] M C Willingham,et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[20] V. Ling,et al. Identification of a sister gene to P-glycoprotein. , 1995, Cancer research.
[21] D. Housman,et al. Mammalian multidrug resistance gene: Complete cDNA sequence indicates strong homology to bacterial transport proteins , 1986, Cell.
[22] J. Beijnen,et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. M. Ford,et al. Pharmacology of drugs that alter multidrug resistance in cancer. , 1990, Pharmacological reviews.
[24] D. Housman,et al. Physical mapping, amplification, and overexpression of the mouse mdr gene family in multidrug-resistant cells , 1990, Molecular and cellular biology.
[25] T. Tsuruo,et al. Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. , 1981, Cancer research.
[26] B. Sikic. Modulation of multidrug resistance: at the threshold. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] D. Housman,et al. The gene encoding multidrug resistance is induced and expressed at high levels during pregnancy in the secretory epithelium of the uterus. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[28] R. Willemze,et al. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. D. de Vries,et al. Establishment of human T lymphocyte clones highly cytotoxic for an EBV-transformed B cell line in serum-free medium: isolation of clones that differ in phenotype and specificity. , 1982, Journal of immunology.
[30] M. Melamed,et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[31] I. Roninson,et al. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells , 1991, Cell.
[32] Michael M. Gottesman,et al. Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells , 1986, Cell.
[33] Piet Borst,et al. Substantial excretion of digoxin via the intestinal mucosa and prevention of long‐term digoxin accumulation in the brain by the mdrla P‐glycoprotein , 1996, British journal of pharmacology.
[34] H. Macdonald,et al. Heterogeneity in P‐glycoprotein (multidrug resistance) activity among murine peripheral T cells: Correlation with surface phenotype and effector function , 1994, European journal of immunology.
[35] M. Gottesman. How cancer cells evade chemotherapy: sixteenth Richard and Hinda Rosenthal Foundation Award Lecture. , 1993, Cancer research.
[36] J. Beijnen,et al. Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL. , 1996, Cancer research.
[37] I. Pastan,et al. Genetic analysis of the multidrug transporter. , 1995, Annual review of genetics.
[38] P. Gros,et al. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities , 1990, Molecular and cellular biology.